LBH Phase II in Small Cell Lung Cancer (SCLC)

Clinical trial NCT01222936 · COMPLETED

Trial details

NCT number: NCT01222936
Sponsor: Southern Europe New Drug Organization
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Carcinoma

Start date: 2008-05-01
Primary completion: 2009-06-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.